Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT02680652 Not yet recruiting - Clinical trials for Common Variable Immune Deficiency (CVID)

Improving the Diagnosis of Common Variable Immune Deficiency

Start date: February 2016
Phase: N/A
Study type: Observational

This is an observational, case--control study with a single blood draw among two cohorts, patients with CVID and healthy controls. Samples will be analyzed by cytometry (CyTOF) to simultaneously examine the major signaling pathways of all circulating innate and adaptive immune cell types as well as whole exome sequencing. The goal is to improve our general understanding of the human immune response to infections and the diagnosis of CVID.

NCT ID: NCT02677519 Not yet recruiting - Clinical trials for Attention Deficit Disorder With Hyperactivity

A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD

EF004
Start date: September 2016
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to evaluate the long-term safety and tolerability of methylphenidate hydrochloride extended-release capsules (Aptensio XR®) in children aged 4-5 years who have been diagnosed with attention-deficit/hyperactivity disorder (ADHD). Safety and tolerability will be evaluated by assessing treatment-emergent adverse events (TEAEs) blood pressure, pulse, height, weight, electrocardiograms (ECGs), laboratory The primary objective of this study is to evaluate the long-term (12-month) safety and tolerability of Aptensio XR® in children aged 4 to less than 6 years who have been diagnosed with ADHD. Safety and tolerability will be evaluated by assessing treatment-emergent adverse events (TEAEs) blood pressure, pulse, height, weight, electrocardiograms (ECGs), laboratory values and Columbia Suicide Severity Rating Scale (C-SSRS). Disturbances in sleep (quantity and quality) patterns will also be assessed using the Child Sleep Habits Questionnaire (CSHQ). Secondary objectives include assessment of long-term efficacy of Aptensio XR®. Secondary measures include: - Investigator administered Attention-Deficit/Hyperactivity Disorder Rating Scale Preschool Version (ADHD-RS-IV Preschool Version) - Clinical Global Impressions-Severity Scale (CGI-S ) - Connors Early Childhood Behavior-Parent Short form [Conners EC BEH-P(S)]

NCT ID: NCT02671201 Not yet recruiting - Clinical trials for Medical Education in Emergency Ultrasound

Training Concepts in Emergency Ultrasonography

Start date: June 2019
Phase:
Study type: Observational

Emergency ultrasound examinations are increasingly important diagnostic tools in emergency and critical care medicine. This study wants to analyze different types of education for undergraduate students. Any method of medical training will be proved theoretical and in clinical practice.

NCT ID: NCT02670889 Not yet recruiting - Clinical trials for Ornithine Transcarbamylase Deficiency

Urease Inhibitor Drug Treatment for Urea Cycle Disorders

Start date: November 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if acetohydroxamic acid (AHA) can prevent hydrolysis of urea by inhibiting the bacterial urease of gut flora of both healthy control adults as well as adults with urea cycle disorders.

NCT ID: NCT02667340 Not yet recruiting - Clinical trials for Effect of Superstarch on Soccer Performance

Superstarch and Physical/Cognitive Performance Following a Simulated Soccer Game

Start date: February 2016
Phase: N/A
Study type: Interventional

To assess the efficacy of a hydrothermally modified starch supplement (Superstarch made byGeneration UCAN) vs isoenergetic placebo (glucose) on exercise performance, execution of specific soccer skills, and on cognitive function during and following a simulated soccer game. Secondary: To compare fat oxidation and carbohydrate oxidation (based on RER data) during the game with Generation UCAN vs isoenergetic placebo (glucose).

NCT ID: NCT02665858 Not yet recruiting - Clinical trials for Pediatric Idiopathic Intracranial Hypertension

OCT Imaging of Papilledema in Pediatric Idiopathic Intracranial Hypertension

Start date: February 2016
Phase: N/A
Study type: Interventional

Longitudinal clinical observation of optic nerve head, using slit lamp fundoscopy, guides therapy in pediatric idiopathic intracranial hypertension (IIH) patients; however, it remains a limited method of producing quantitative data in evaluating in patients with IIH. In this study we intend to compare, by using spectral domain optical coherence tomography (OCT), the mean retinal nerve fiber layer thickness and total retinal thickness (RNFLT/TRT) of the optic nerve of newly diagnosed IIH children to a control group. This will provide a quantitative measure for follow-up and treatment of this patient group.

NCT ID: NCT02665806 Not yet recruiting - Clinical trials for Chronic Rhinosinustis With Polyps

Ciclesonide vs Fluticasone Nasal Sprays in Nasal Poplyposis

Start date: January 2016
Phase: Phase 3
Study type: Interventional

This study is designed to compare ciclesonide nasal spray once daily with fluticasone propionate aquas nasal spray BD, which is commonly prescribed in patients with nasal polyposis, in order to relieve symptoms of these patients.

NCT ID: NCT02654392 Not yet recruiting - Clinical trials for Effect of Essential Fatty Acids on Exercise Performance

Effect of Plant Omega-3 and Omega-6 Fatty Acids on Exercise Performance

Start date: February 2016
Phase: N/A
Study type: Interventional

Many studies in the past three decades have examined the beneficial effects of omega-3 polyunsaturated fatty acids in diet and supplementation. The effect of polyunsaturated fatty acids, specifically omega-3 and omega-6, on health have been well-studied but most of the study to date has been on animal not plant sources and much less is know about their effects on exercise performance. Additionally, while positive effects have been detected for sedentary populations or those that are at risk, well-trained athletes generally have not had established advantages in taking supplements for omega-3 and omega-6 oils. There is evidence that a specific ratio of omega-6 to omega-3 is most beneficial for the human body with regards to cardiovascular and mental health. In this study, participants randomized to either a plant supplement group (pureform omega; containing Flax, Evening Primrose, Sunflower, Coconut & Pumpkin oils; Natural Product Number = 80050660) or placebo (isoenergetic sugar pills) will be subjected to both a time trial and a high intensity interval bout, where their performance and power output will be analyzed. Blood lactate and glucose concentration, as well as oxygen consumption and carbon dioxide production will also be examined to determine if there is a change in on fat oxidation after supplementation.

NCT ID: NCT02649413 Not yet recruiting - Clinical trials for Nephrotic Syndrome, Minimal Change

Adjusted Steroids Therapy in Childerens With Idiopathic Nephrotic Syndrome

AJSNS
Start date: March 2016
Phase: Phase 4
Study type: Interventional

The initial steroids dose for Nephrotic Syndrome is 60mg/1m2 for 6-4 weeks and the duration of the first steroid course is between 8 weeks to 6 months. The base of the initial dose for steroids Idiopathic nephrotic syndrome been put in the early 70s. In our study the investigators will adjusted the first steroids does to the response day. Our primary end point is : a lower adjusted dose is as good as the fix dose in the first year after diagnosis.

NCT ID: NCT02649283 Not yet recruiting - Clinical trials for Breast Asymmetry Between Native Breast and Reconstructed Breast

Performance of OrbiSymm in Subjects Referred to Contra Lateral Breast Symmetrisation

Start date: October 2016
Phase: N/A
Study type: Interventional

This is a Phase IV, multicenter, open label, non-randomized comparative group study to assess the safety and performance of the OrbiSymm system in subjects referred to contra lateral breast symmetrization involving a breast reduction following breast reconstruction post-mastectomy.